Stay updated with breaking news from Human Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
'A significant milestone in the field of chronic kidney disease' The European Commission (EC) approved Jardiance® (empagliflozin) for the treatment of
Threads growth has slowed by 90% in August to an average of 440,000 new users per day...
The European Commission (EC) approved Jardiance® (empagliflozin) for the treatment of adults with chronic kidney disease (CKD)[viii], Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced today. The approval has the potential to advance the standard of care for more than 47 million people in the EU ...
The maker of HEARTGARD® Plus (ivermectin/pyrantel), the #1 vet-recommended and #1 dog-preferred real beef chew,1, 2 introduces the latest innovation in its...
The Stable Life initiative seeks to support veterinarians through resources and education.